Allurion Technologies (ALUR) Shares Outstanding (2022 - 2026)
Allurion Technologies (ALUR) posted Shares Outstanding (Entity) of $15.0 million for Q1 2026, up 98.75% on a QoQ basis from $7.5 million in Q4 2025, and up 213.79% year-over-year from $4.8 million in Q1 2025.
Allurion Technologies (ALUR) Shares Outstanding (2022 - 2026) Analysis & Trends
Allurion Technologies' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $15.0 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) rose 213.79% year-over-year to $15.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.0 million (up 213.79% YoY) and the FY2025 annual result came in at $7.5 million, up 235.74% from the prior year.
- Shares Outstanding (Entity) was $15.0 million for Q1 2026 at Allurion Technologies, up from $7.5 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $15.0 million in Q1 2026 and bottomed at $298704.0 in Q2 2022.
- A 5-year average of $4.0 million and a median of $1.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) rose 3.1% — and 2025, when it surged 545.89%.
- Allurion Technologies' Shares Outstanding (Entity) stood at $1.1 million in 2022, then surged by 32.18% to $1.4 million in 2023, then surged by 57.89% to $2.2 million in 2024, then jumped by 235.74% to $7.5 million in 2025, then jumped by 98.75% to $15.0 million in 2026.
- Business Quant data shows ALUR's Shares Outstanding (Entity) at $15.0 million in Q1 2026, $7.5 million in Q4 2025, and $13.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Allurion Technologies | 74.67 Mn | 69.62 Mn | 1.23 Mn | 13.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.35 Mn |
| Dec 31, 2025 | 7.54 Mn |
| Sep 30, 2025 | 13.77 Mn |
| Jun 30, 2025 | 7.30 Mn |
| Mar 31, 2025 | 4.78 Mn |
| Dec 31, 2024 | 2.25 Mn |
| Sep 30, 2024 | 2.13 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 1.91 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 307,174.00 |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 1.08 Mn |
| Jun 30, 2022 | 298,704.00 |